We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
246
Reduced
378
Closed
79
Avg Time Held
5.2
quarters
Top 10 Avg Time Held
4.8
quarters
Top 20 Avg Time Held
4.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Truist Financial
TFC
$55.6B
| $626M | 0.93% |
16,047,513
+2,673,160
| +20% | +$101M |
2013 Q2
7 quarters
|
|
27
Marathon Petroleum
MPC
$134B
| $622M | 0.93% |
12,140,402
+452,026
| +4% | +$21.7M |
2013 Q2
7 quarters
|
|
28
Chubb
CB
$134B
| $620M | 0.92% |
5,561,113
-193,975
| -3% | -$21.8M |
2013 Q2
7 quarters
|
|
29
DELISTED
Discover Financial Services
DFS
| $616M | 0.92% |
10,928,231
+1,827,619
| +20% | +$108M |
2013 Q2
7 quarters
|
|
|
OCR
30
DELISTED
OMNICARE INC
OCR
| $589M | 0.88% |
7,647,699
+54,010
| +0.7% | +$4.1M |
2013 Q2
7 quarters
|
|
31
Fifth Third Bancorp
FITB
$44.8B
| $586M | 0.87% |
31,108,491
-10,538,442
| -25% | -$199M |
2013 Q2
7 quarters
|
|
32
Teva Pharmaceutical Industries Limited
TEVA
$48.8B
| $560M | 0.83% |
8,993,700
-206,302
| -2% | -$12M |
2013 Q2
7 quarters
|
|
|
RTN
33
DELISTED
Raytheon Company
RTN
| $532M | 0.79% |
4,872,829
-176,647
| -3% | -$19M |
2013 Q2
7 quarters
|
|
34
Occidental Petroleum
OXY
$61.7B
| $532M | 0.79% |
7,303,958
-50,251
| -0.7% | -$3.89M |
2013 Q2
7 quarters
|
|
35
Macy's
M
$5.7B
| $529M | 0.79% |
8,142,099
-345,643
| -4% | -$22.2M |
2013 Q2
7 quarters
|
|
36
Travelers Companies
TRV
$78.2B
| $525M | 0.78% |
4,858,469
-155,174
| -3% | -$16.6M |
2013 Q2
7 quarters
|
|
37
Tyson Foods
TSN
$18.9B
| $513M | 0.76% |
13,388,518
+1,534,711
| +13% | +$61.4M |
2013 Q2
7 quarters
|
|
|
BRCD
38
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $490M | 0.73% |
41,294,564
-1,176,288
| -3% | -$14M |
2013 Q2
7 quarters
|
|
|
EGN
39
DELISTED
Energen
EGN
| $449M | 0.67% |
6,801,086
+253,795
| +4% | +$16.3M |
2013 Q2
7 quarters
|
|
40
Aon
AON
$58.2B
| $442M | 0.66% |
4,598,111
+635,843
| +16% | +$61.5M |
2014 Q4
1 quarter
|
|
41
Delta Air Lines
DAL
$50.6B
| $431M | 0.64% |
9,591,110
+123,076
| +1% | +$5.71M |
2014 Q2
3 quarters
|
|
42
Crown Holdings
CCK
$11.9B
| $431M | 0.64% |
7,974,334
-1,094,323
| -12% | -$54.4M |
2013 Q2
7 quarters
|
|
43
AbbVie
ABBV
$502B
| $422M | 0.63% |
7,215,366
+1,476,631
| +26% | +$89.2M |
2013 Q2
7 quarters
|
|
|
44
Gilead Sciences
GILD
$188B
| $417M | 0.62% |
4,246,579
+2,694,732
| +174% | +$274M |
2014 Q4
1 quarter
|
|
45
Graphic Packaging
GPK
$2.45B
| $416M | 0.62% |
28,592,052
+2,720,914
| +11% | +$39.8M |
2013 Q2
7 quarters
|
|
46
AES
AES
$10.7B
| $410M | 0.61% |
31,916,333
+1,664,034
| +6% | +$20.8M |
2013 Q2
7 quarters
|
|
47
Fidelity National Information Services
FIS
$17.9B
| $409M | 0.61% |
6,010,326
+11,027
| +0.2% | +$721K |
2014 Q1
4 quarters
|
|
48
EQT Corp
EQT
$33.4B
| $404M | 0.6% |
8,964,621
-925,939
| -9% | -$39.3M |
2013 Q2
7 quarters
|
|
49
Canadian Natural Resources
CNQ
$107B
| $390M | 0.58% |
26,247,050
+1,164,476
| +5% | +$16.7M |
2013 Q2
7 quarters
|
|
50
ON Semiconductor
ON
$28.5B
| $385M | 0.57% |
31,811,039
-6,821,100
| -18% | -$78.1M |
2013 Q2
7 quarters
|
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 246 increased, 378 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.